Neo Borocillina Gola Dolore Gusto Arancia E Miele (Flurbiprofen)

Flurbiprofen, the active ingredient in Neo Borocillina Gola Dolore Gusto Arancia E Miele, is a nonsteroidal anti‑inflammatory drug (NSAID) presented as an oropharyngeal preparation for local relief of throat discomfort and oral mucosal inflammation. It works by reducing prostaglandin production at the site of pain, providing symptomatic relief for sore throat and related conditions.

GNH USA supplies Neo Borocillina Gola Dolore Gusto Arancia E Miele as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Flurbiprofen acts locally in the oropharynx to alleviate inflammation‑related pain in the upper digestive tract.

- Sore throat pain: provides rapid symptomatic relief of throat discomfort. - Oral mucosal inflammation: reduces swelling and pain of inflamed oral tissues. - Pharyngitis: eases pain associated with inflammation of the pharyngeal mucosa.

Flurbiprofen may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Taste alteration: temporary change in flavor perception. - Mild oral irritation: slight burning or tingling in the mouth. - Nausea: occasional feeling of queasiness. - Headache: mild headache during early use. - Dyspepsia: mild stomach discomfort.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Gastrointestinal ulceration: bleeding or perforation of the stomach or intestine. - Renal impairment: reduced kidney function, especially with prolonged use. - Cardiovascular events: increased risk of heart attack or stroke in susceptible individuals. - Hematologic abnormalities: rare blood clotting disorders.

When using Flurbiprofen for throat relief, consider the following safety measures.

- Hypersensitivity: avoid if the patient has known allergy to NSAIDs or flurbiprofen. - Gastrointestinal risk: use with caution in patients with a history of ulcers or GI bleeding. - Renal function: monitor kidney function in patients with existing renal impairment. - Cardiovascular caution: assess cardiovascular risk in patients with heart disease or hypertension. - Duration of therapy: do not exceed the recommended short‑term use without medical supervision. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Flurbiprofen can interact with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Concomitant NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or diuretics: may impair renal function, especially in dehydrated patients. - Lithium: flurbiprofen can raise lithium serum levels, requiring close monitoring.